Home » Topics » BioWorld Science

BioWorld Science
RSS

DYRK2 is a critical checkpoint in the control of leukemia stem cell maintenance

Dec. 13, 2019

Innovent Biologics presents PI3K inhibitors

Dec. 13, 2019

Adlai Nortye divulges new CSF1R inhibitors

Dec. 13, 2019

Antabio SAS patents new antibacterial compounds

Dec. 13, 2019

DPP8 may be a target for multiple myeloma therapy by inducing apoptotic cell death

Dec. 13, 2019

New long-acting HIV-1 fusion inhibitor-based regimen developed

Dec. 13, 2019

First phase III data for YF-H-2015005 shows rapid mobilization of CD34+ cells

Dec. 13, 2019

Kaleido to advance KB-174 for HE based on topline data from study in patients with cirrhosis

Dec. 13, 2019

Soligenix initiates phase Ic study of RiVax

Dec. 13, 2019

Prescient presents promising interim phase Ib data for PTX-200 in ovarian cancer

Dec. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...